Progenics Pharmaceuticals, Inc. (PGNX) Given Consensus Recommendation of "Buy" by Brokerages

Progenics Pharmaceuticals, Inc. (PGNX) Given Consensus Recommendation of "Buy" by Brokerages

Progenics Pharmaceuticals, Inc. has received an average recommendation of "Buy" from the six research firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company.

from Biotech News